Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.
- Published In:
- Acta gastro-enterologica Belgica, 89(1), 13-24 (2026)
- Authors:
- Lazarenko, I, Mileva, M, Manta, R, Kristanto, P, Hendlisz, A, Van Laethem, J L, Wimana, Z, Artigas, C, Flamen, P, Karfis, I
- Database ID:
- RPEP-15487
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15487APA
Lazarenko, I; Mileva, M; Manta, R; Kristanto, P; Hendlisz, A; Van Laethem, J L; Wimana, Z; Artigas, C; Flamen, P; Karfis, I. (2026). Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.. Acta gastro-enterologica Belgica, 89(1), 13-24. https://doi.org/10.51821/89.1.14882
MLA
Lazarenko, I, et al. "Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.." Acta gastro-enterologica Belgica, 2026. https://doi.org/10.51821/89.1.14882
RethinkPeptides
RethinkPeptides Research Database. "Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor ..." RPEP-15487. Retrieved from https://rethinkpeptides.com/research/lazarenko-2026-realworld-outcomes-of-177luludotatate
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.